Bolt Biotherapeutics, Inc. (BOLT) KPIs and segments
BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 11/3030% below fair value
$6.08+0.17 (+2.88%)
Close on Nov 13, 2026Market cap $11.71MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Bolt Biotherapeutics's business
Coming soon
This tab will track the numbers specific to Bolt Biotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?